Sloan Kettering executive reduces sudden stake in biotechnology start – New York Times

The top cancer researcher failed to disclose financial companies relations in major research journals

September. 8, 2018Image

Sloan Kettering comfortable in dealing with start to feel a new sensation

September. 20, 2018Image

Top Sloan Kettering Cancer the doctor resigns after failing to disclose industry ties

September. 13, 2018Image

Cancer Center the keys to focus on fund-raising problems mount

September. 25, 2018Image

More in health

imagem02-10-2018-18-10-34[/commentary]Eamon Queeney the New York Times

These cholesterol-reducers may save lives. Why don’t heart patients get it?

[caption id="attachment_28267" align="aligncenter" width="600"]imagem02-10-2018-18-10-34 imagem02-10-2018-18-10-34[/commentary]eye of Science/Science Source

Breakthrough the treatment of leukemia is associated in rare case

[caption id="attachment_28268" align="aligncenter" width="600"]imagem02-10-2018-18-10-35 imagem02-10-2018-18-10-35[/commentary]Robert Nicol

The secret of aging? The bomb

[caption id="attachment_28269" align="aligncenter" width="600"]imagem02-10-2018-18-10-36 imagem02-10-2018-18-10-36

Jonathan Nackstrand/Agence France-Presse — Getty

The 2018 Nobel Prize in Medicine awarded 2 for Immunotherapy of cancer researchers

imagem02-10-2018-18-10-36[/commentary]Gracia Lam

The risk alternative cancer treatments

[caption id="attachment_28271" align="aligncenter" width="600"]imagem02-10-2018-18-10-37 imagem02-10-2018-18-10-37

Joshua Bright of the New York Times

More than 80, 000 Americans died of the flu last winter, the highest toll in years.



Seja o primeiro a comentar

Faça um comentário

Seu e-mail não será publicado.